BIOS Capital Management, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ACTUATE THERAPEUTICS INC | 9,965,079 | 10,049,996 | +84,917 | 60,886,633 | 67,234,473 | 75.62% | +6,347,840 |
| COGNITION THERAPEUTICS INC | 6,000,000 | 6,000,000 | 0 | 1,860,000 | 8,100,000 | 9.11% | +6,240,000 |
| OPUS GENETICS INC | 3,683,429 | 3,683,429 | 0 | 3,462,423 | 6,593,338 | 7.42% | +3,130,915 |
| LANTERN PHARMA INC | 1,075,952 | 1,015,715 | -60,237 | 3,400,008 | 4,418,360 | 4.97% | +1,018,352 |
| IN8BIO INC | 286,664 | 286,664 | 0 | 599,128 | 622,061 | 0.70% | +22,933 |
| REIN THERAPEUTICS INC | 1,690,751 | 1,690,751 | 0 | 2,367,051 | 1,944,364 | 2.19% | -422,687 |